Siyuan Zhou

Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors

Hai-bin Luo, Deyan Wu, Chen Zhang, 2017, Journal of Molecular Modeling.

Design of Xenopus GLP-1-Based Long-Acting Dual GLP-1/Y2 Receptor Agonists.

Weizhong Tang, Jing Han, Yongliang Yuan, 2022, Journal of medicinal chemistry.

Discovery of once-weekly, peptide-based selective GLP-1 and cholecystokinin 2 receptors co-agonizts

Jing Han, Qimeng Yang, Feng Zhou, 2022, Peptides.

Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.

W. Cornell, R. Tommasi, S. Xue, 2009, Journal of medicinal chemistry.

N-arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B.

R. Tommasi, D. Farley, S. Cowen, 2003, Bioorganic & medicinal chemistry letters.

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2

L. Urbán, R. Fujimoto, Xiaoli Zhang, 2005, British journal of pharmacology.

Discovery of once-weekly, peptide-based selective GLP-1 and cholecystokinin 2 receptors co-agonizts

Jing Han, Qimeng Yang, Feng Zhou, 2022, Peptides.